Taken together, these findings indicate that Ulk1 deletion remodels the tumor immune microenvironment by reducing tumor-promoting myeloid cells such as M2 macrophages and neutrophils or PMN-MDSCs, and increasing cytotoxic T cells and APCs, leading to enhanced antitumor immunity and suppressed tumor growth. Here, ULK1 is linked to neoplasm.